317 Farmasia

Ylätieteenala(t)

Julkaisut ja muut tuotokset

  

  

  

1/3

  

  

  

• Activation of p53 signaling and regression of breast and prostate carcinoma cells by spirooxindole-benzimidazole small molecules (2024) Barakat, Assem; et al.; A1; OA
• Azulene as a biphenyl mimetic in orexin/hypocretin receptor agonists (2023) Leino, Teppo O.; et al.; A1; OA
• Discovery of Potent Indolyl-Hydrazones as Kinase Inhibitors for Breast Cancer : Synthesis, X-ray Single-Crystal Analysis, and In Vitro and In Vivo Anti-Cancer Activity Evaluation (2023) Salama, Eid E.; et al.; A1; OA
• Simultaneous Determination of Selected Antidiabetic Pharmaceutical Drugs as Adulterants in Herbal Medicines Sold in Kenya Using Liquid Chromatography–Tandem Mass Spectrometry (LC–MS/MS) (2023) Maina, C.; et al.; A1; OA
• Synthesis and SARs study of novel spiro‐oxindoles as potent antiproliferative agents with CDK‐2 inhibitory activities (2023) Al‐Jassas, Refaah Mousa; et al.; A1
• Vemurafenib Inhibits Acute and Chronic Enterovirus Infection by Affecting Cellular Kinase Phosphatidylinositol 4-Kinase Type IIIβ (2023) Laajala, Mira; et al.; A1; OA
• Acetic Acid Mediated for One-Pot Synthesis of Novel Pyrazolyl s-Triazine Derivatives for the Targeted Therapy of Triple-Negative Breast Tumor Cells (MDA-MB-231) via EGFR/PI3K/AKT/mTOR Signaling Cascades (2022) Shawish, Ihab; et al.; A1; OA
• New Bioprecursor Prodrugs of Sulfadiazine : Synthesis, X-ray Structure and Hirshfeld Analysis (2022) Altowyan, Mezna Saleh; et al.; A1; OA
• Computational cytochrome P450 mediated metabolism and virtual screening (2021) Ahinko, Mira; G5; OA; 978-951-39-8496-0
• Development of New Coumarin-Based Profluorescent Substrates for Human Cytochrome P450 Enzymes (2019) Juvonen, Risto O.; et al.; A1; OA